This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2019 Aug;140(2):182-183.

doi: 10.1111/acps.13063.

Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression

R Pérez-Esparza^{1

2}, L F Kobayashi-Romero¹, A M García-Mendoza¹, R M Lamas-Aguilar², A Fonseca-Perezamador¹

Affiliations

Affiliations

¹ Addiction Research Laboratory, National Institute of Neurology and Neurosurgery, Mexico City.
² Department of Neuropsychiatry, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.

PMID: 31251388
DOI: 10.1111/acps.13063

Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression

R Pérez-Esparza et al. Acta Psychiatr Scand. 2019 Aug.

. 2019 Aug;140(2):182-183.

doi: 10.1111/acps.13063.

Authors

R Pérez-Esparza^{1

2}, L F Kobayashi-Romero¹, A M García-Mendoza¹, R M Lamas-Aguilar², A Fonseca-Perezamador¹

Affiliations

¹ Addiction Research Laboratory, National Institute of Neurology and Neurosurgery, Mexico City.
² Department of Neuropsychiatry, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.

PMID: 31251388
DOI: 10.1111/acps.13063

No abstract available

PubMed Disclaimer

Similar articles

Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
De Gioannis A, De Leo D. De Gioannis A, et al. Aust N Z J Psychiatry. 2014 Jul;48(7):686. doi: 10.1177/0004867414520754. Epub 2014 Jan 22. Aust N Z J Psychiatry. 2014. PMID: 24452289 No abstract available.
Esketamine nasal spray (Spravato) for treatment-resistant depression.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Apr 8;61(1569):54-57. Med Lett Drugs Ther. 2019. PMID: 31169797 No abstract available.
[Ketamine for treatment of acute depression].
Hjerrild S, Bjerre J, Pedersen RH, Videbech P. Hjerrild S, et al. Ugeskr Laeger. 2013 Sep 9;175(37):2090-3. Ugeskr Laeger. 2013. PMID: 24011203 Review. Danish.
Esketamine: A Novel Option for Treatment-Resistant Depression.
Bozymski KM, Crouse EL, Titus-Lay EN, Ott CA, Nofziger JL, Kirkwood CK. Bozymski KM, et al. Ann Pharmacother. 2020 Jun;54(6):567-576. doi: 10.1177/1060028019892644. Epub 2019 Dec 4. Ann Pharmacother. 2020. PMID: 31795735 Review.
Esketamine: A Drug to Treat Resistant Depression That Brings More Questions Than Answers.
Mischel NA, Balon R. Mischel NA, et al. J Clin Psychopharmacol. 2021 May-Jun 01;41(3):233-235. doi: 10.1097/JCP.0000000000001395. J Clin Psychopharmacol. 2021. PMID: 33905639 Free PMC article. No abstract available.

See all similar articles

Cited by

Role of Ketamine in the Treatment of Psychiatric Disorders.
Derakhshanian S, Zhou M, Rath A, Barlow R, Bertrand S, DeGraw C, Lee C, Hasoon J, Kaye AD. Derakhshanian S, et al. Health Psychol Res. 2021 Jun 22;9(1):25091. doi: 10.52965/001c.25091. eCollection 2021. Health Psychol Res. 2021. PMID: 35106397 Free PMC article. Review.
Ketamine: Leading us into the future for development of antidepressants.
Carreno FR, Lodge DJ, Frazer A. Carreno FR, et al. Behav Brain Res. 2020 Apr 6;383:112532. doi: 10.1016/j.bbr.2020.112532. Epub 2020 Feb 2. Behav Brain Res. 2020. PMID: 32023492 Free PMC article. Review.
"Novel Psychopharmacology for Depressive Disorders".
Fornaro M, De Berardis D, Anastasia A, Fusco A. Fornaro M, et al. Adv Exp Med Biol. 2021;1305:449-461. doi: 10.1007/978-981-33-6044-0_22. Adv Exp Med Biol. 2021. PMID: 33834412 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information